Evidence map›Paper›PMID 40766925›Full record

SynthesisFrontiers in psychiatry2025

Implementation of generative AI for the assessment and treatment of autism spectrum disorders: a scoping review.

Jun-Seok Sohn, Eojin Lee, Jae-Jin Kim, Hyang-Kyeong Oh, Eunjoo Kim

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Toward FIAPFrontiers in neuroinformatics · 2026
    Article
  6. Article
  7. AnFrontiers in psychiatry · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jun-Seok SohnDepartment of Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Eojin LeeInstitute of Behavioral Sciences in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jae-Jin KimInstitute of Behavioral Sciences in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Hyang-Kyeong OhInstitute of Behavioral Sciences in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Eunjoo KimInstitute of Behavioral Sciences in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Autism spectrum disorder (ASD) is characterized by persistent deficits in social communication and restrictive, repetitive behaviors. Current diagnostic and intervention pathways rely heavily on clinician expertise, leading to delays and limited scalability. Generative artificial intelligence (GenAI) offers emerging opportunities for automatically assisting and personalizing ASD care, though technical and ethical concerns persist. Methods: We conducted systematic searches in Embase, PsycINFO, PubMed, Scopus, and Web of Science (January 2014 to February 2025). Two reviewers independently screened and extracted eligible studies reporting empirical applications of GenAI in ASD screening, diagnosis, or intervention. Data were charted across GenAI architectures, application domains, evaluation metrics, and validation strategies. Comparative performance against baseline methods was synthesized where available. Results: From 553 records, 10 studies met the inclusion criteria across three domains: (1) screening and diagnosis (e.g., transformer-based classifiers and GAN-based data augmentation), (2) assessment and intervention, (e.g., multimodal emotion recognition and feedback systems), and (3) caregiver education and support (e.g., LLM-based chatbots). While most studies reported potential performance improvements, they also highlighted limitations such as small sample sizes, data biases, limited validation, and model hallucinations. Comparative analyses were sparse and lacked standardized metrics. Discussion: This review (i) maps GenAI applications in ASD care, (ii) compares GenAI and traditional approaches, (iii) highlights methodological and ethical challenges, and (iv) proposes future research directions. Our findings underscore GenAI's emerging potential in autism care and the prerequisites for its ethical, transparent, and clinically validated implementation. Systematic review registration: https://osf.io/4gsyj/, identifier DOI: 10.17605/OSF.IO/4GSYJ.

Indexed as

autism spectrum disorderdeep learninggenerative artificial intelligencelarge language modelmachine learningmental healthnatural language processingscoping review

Identifiers

PMID40766925
PMCPMC12322814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.